NCT07136467 A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
| NCT ID | NCT07136467 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AbbVie |
| Condition | Non-Segmental Vitiligo (NSV) |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,795 participants |
| Start Date | 2025-09-02 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,795 participants in total. It began in 2025-09-02 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.
Eligibility Criteria
Inclusion Criteria: * Participants with Physician-confirmed diagnosis of non-segmental vitiligo (NSV), moderate to severe Alopecia Areata (AA), or moderate to severe hidradenitis suppurativa (HS) * Participants Ability to understand study questionnaires, with caregiver support as required for adolescents Exclusion Criteria: * Participating in interventional clinical trial(s) at time of study visit (participation in another non-interventional study or registry does not exclude a participant from this study) * Unable or unwilling to comply with study requirements and PRO collection
Contact & Investigator
ABBVIE INC.
STUDY DIRECTOR
AbbVie
Frequently Asked Questions
Who can join the NCT07136467 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, studying Non-Segmental Vitiligo (NSV). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07136467 currently recruiting?
Yes, NCT07136467 is actively recruiting participants. Contact the research team at beth.rycroft@abbvie.com for enrollment information.
Where is the NCT07136467 trial being conducted?
This trial is being conducted at Ciudad Autonoma de Buenos Aire, Argentina, Buenos Aires, Argentina, Buenos Aires, Argentina, Buenos Aires, Argentina and 11 additional locations.
Who is sponsoring the NCT07136467 clinical trial?
NCT07136467 is sponsored by AbbVie. The principal investigator is ABBVIE INC. at AbbVie. The trial plans to enroll 2,795 participants.